Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy
出版年份 2017 全文链接
标题
Umeclidinium in chronic obstructive pulmonary disease: latest evidence and place in therapy
作者
关键词
-
出版物
Therapeutic Advances in Chronic Disease
Volume 8, Issue 4-5, Pages 81-91
出版商
SAGE Publications
发表日期
2017-03-24
DOI
10.1177/2040622317700822
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis
- (2016) Roy A. Pleasants et al. DRUGS
- Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial
- (2016) Dave Singh et al. LANCET
- Dual Bronchodilator Therapy with Umeclidinium/Vilanterol Versus Tiotropium plus Indacaterol in Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial
- (2016) Chris Kalberg et al. Drugs in research & development
- A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 µg compared with tiotropium 18 µg in patients with COPD
- (2016) Gregory Feldman et al. International Journal of Chronic Obstructive Pulmonary Disease
- The effect of umeclidinium added to inhaled corticosteroid/long-acting β2-agonist in patients with symptomatic COPD: a randomised, double-blind, parallel-group study
- (2016) Ana R Sousa et al. npj Primary Care Respiratory Medicine
- Vilanterol trifenatate for the treatment of COPD
- (2016) Mario Malerba et al. Expert Review of Respiratory Medicine
- A Systematic Review of the Efficacy and Safety of a Fixed-Dose Combination of Umeclidinium and Vilanterol for the Treatment of COPD
- (2015) Gustavo J. Rodrigo et al. CHEST
- Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers
- (2015) Noushin Brealey et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Pharmacokinetics and Tolerability of Inhaled Umeclidinium and Vilanterol Alone and in Combination in Healthy Chinese Subjects: A Randomized, Open-Label, Crossover Trial
- (2015) Chaoying Hu et al. PLoS One
- Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD
- (2014) Bartolome Celli et al. CHEST
- Population Pharmacokinetics of Inhaled Umeclidinium and Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
- (2014) Navin Goyal et al. CLINICAL PHARMACOKINETICS
- A randomized, placebo- and moxifloxacin-controlled thorough QT study of umeclidinium monotherapy and umeclidinium/vilanterol combination in healthy subjects
- (2014) Dennis Kelleher et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of umeclidinium/vilanterol 62.5/25 mcg and tiotropium 18 mcg in chronic obstructive pulmonary disease: Results of a 24-week, randomized, controlled trial
- (2014) M. Reza Maleki-Yazdi et al. RESPIRATORY MEDICINE
- Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials
- (2014) Marc Decramer et al. Lancet Respiratory Medicine
- Novel anti-cholinergics in COPD
- (2013) A. Prakash et al. DRUG DISCOVERY TODAY
- Umeclidinium in patients with COPD: a randomised, placebo-controlled study
- (2013) R. Trivedi et al. EUROPEAN RESPIRATORY JOURNAL
- Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD
- (2013) J.F. Donohue et al. RESPIRATORY MEDICINE
- Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
- (2013) Rashmi Mehta et al. International Journal of Chronic Obstructive Pulmonary Disease
- Muscarinic Receptors and Their Antagonists in COPD: Anti-Inflammatory and Antiremodeling Effects
- (2012) George Karakiulakis et al. MEDIATORS OF INFLAMMATION
- Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Umeclidinium and Vilanterol Alone and in Combination: A Randomized Crossover Trial
- (2012) Dennis L. Kelleher et al. PLoS One
- A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD
- (2012) James F. Donohue et al. RESPIRATORY MEDICINE
- Comparison of three combined pharmacological approaches with tiotropium monotherapy in stable moderate to severe COPD: A systematic review
- (2011) Gustavo J. Rodrigo et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Heparin Induces Rat Aorta Relaxation via Integrin-Dependent Activation of Muscarinic M 3 Receptors
- (2010) Edgar J. Paredes-Gamero et al. HYPERTENSION
- Synthesis and Structure−Activity Relationships of Long-acting β2Adrenergic Receptor Agonists Incorporating Metabolic Inactivation: An Antedrug Approach
- (2010) Panayiotis A. Procopiou et al. JOURNAL OF MEDICINAL CHEMISTRY
- Unknown
- (2010) G. Villetti et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Mono- and Combination Therapy of Long-Acting Bronchodilators and Inhaled Corticosteroids in Advanced COPD
- (2010) Jill Ohar et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey
- (2009) Martyn R. Partridge et al. CURRENT MEDICAL RESEARCH AND OPINION
- COPD: what is the unmet need?
- (2008) P M A Calverley BRITISH JOURNAL OF PHARMACOLOGY
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
- (2008) Donald P. Tashkin et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now